Loading…
Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy
In this study, we synthesized and characterized 3-hydroxypyridin-2-thione (3-HPT) bearing zinc ( ZnPc-1 and ZnPc-2 ) and indium ( InPc-1 and InPc-2 ) phthalocyanine (Pc) derivatives, either non-peripherally or peripherally substituted as photosensitizer (PS) agents and evaluated their anti-cancer ef...
Saved in:
Published in: | RSC advances 2021-10, Vol.11 (55), p.34963-34978 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this study, we synthesized and characterized 3-hydroxypyridin-2-thione (3-HPT) bearing zinc (
ZnPc-1
and
ZnPc-2
) and indium (
InPc-1
and
InPc-2
) phthalocyanine (Pc) derivatives, either non-peripherally or peripherally substituted as photosensitizer (PS) agents and evaluated their anti-cancer efficacy on two breast cancer cell lines, MDA-MB-231 and MCF-7 as well as a human endothelial cell line, HUVEC. Our results indicated different localization patterns between
ZnPcs
and
InPcs
in addition to enhanced effects on the mitochondrial network for
InPcs
. Moreover, peripheral or non-peripheral substitution of
HDACi
moieties altered cellular localization between
ZnPc-1
and
ZnPc-2
, leading to increased IC
50
values along with decreased anti-cancer activity for non-peripheral substitution. When considering the compounds' differential effects
in vitro
, our data indicates that further research is required to determine the ideal Pcs for anti-cancer PDT treatments since the core metals of the compounds have affected the cellular localization, and positioning of the chemotherapeutic residues may inhibit cellular penetrance.
3-Hydroxypyridin-2-thione bearing zinc and indium phthalocyanine derivatives, as photosensitizer agents have been synthesized and evaluated for their anti-cancer efficacy on two breast cancer cell lines, MDA-MB-231 and MCF-7 as well as a human endothelial cell line, HUVEC. |
---|---|
ISSN: | 2046-2069 2046-2069 |
DOI: | 10.1039/d1ra05404j |